Hoba Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$25M
- Investors
-
7
Hoba Therapeutics General Information
Description
Developer of medical therapeutics designed to assist in neuropathic pain and CNS disorders treatments. The company specializes in developing novel biopharmaceuticals for the relief, prevention, and treatment of chronic pain and hearing loss, and advancing a novel therapeutic protein targeting the cells, enabling medical practitioners with innovative, effective, safe, and disease-modifying treatments for patients living with neuropathic pain.
Contact Information
Website
www.hobatherapeutics.comCorporate Office
- Ole Maaløesvej
- 2200 Copenhagen
- Denmark
Corporate Office
- Ole Maaløesvej
- 2200 Copenhagen
- Denmark
Hoba Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A) | 11-Dec-2023 | $25M | Completed | Clinical Trials - Phase 1 | ||
| 6. Secondary Transaction - Private | Completed | Clinical Trials - Phase 1 | ||||
| 5. Later Stage VC | 07-Jul-2022 | Completed | Clinical Trials - Phase 1 | |||
| 4. Grant | 16-Jun-2021 | Completed | Clinical Trials - Phase 1 | |||
| 3. Seed Round | 22-May-2019 | Completed | Clinical Trials - Phase 1 | |||
| 2. Seed Round | 20-Sep-2018 | $4M | $6.03M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 02-Dec-2016 | $2.03M | $2.03M | Completed | Pre-Clinical Trials |
Hoba Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 215,384 | $9.46 | $9.46 | 1x | $9.46 | 9.07% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Hoba Therapeutics Patents
Hoba Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022405685-A1 | Treatment of nociceptive pain | Pending | 10-Dec-2021 | ||
| CA-3239550-A1 | Treatment of nociceptive pain | Pending | 10-Dec-2021 | ||
| EP-4444338-A1 | Treatment of nociceptive pain | Pending | 10-Dec-2021 | ||
| US-20250325627-A1 | Treatment of nociceptive pain | Pending | 10-Dec-2021 | ||
| WO-2023104960-A1 | Treatment of nociceptive pain | Inactive | 10-Dec-2021 | A61K38/1709 |
Hoba Therapeutics Signals
Hoba Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Indaco Venture Partners | Venture Capital | Minority | ||
| Medical Incubator Japan | Venture Capital | Minority | ||
| Eir Ventures | Venture Capital | Minority | ||
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Denmark's Export and Investment Fund | Venture Capital | Minority |
Hoba Therapeutics FAQs
-
When was Hoba Therapeutics founded?
Hoba Therapeutics was founded in 2016.
-
Where is Hoba Therapeutics headquartered?
Hoba Therapeutics is headquartered in Copenhagen, Denmark.
-
What is the size of Hoba Therapeutics?
Hoba Therapeutics has 9 total employees.
-
What industry is Hoba Therapeutics in?
Hoba Therapeutics’s primary industry is Drug Discovery.
-
Is Hoba Therapeutics a private or public company?
Hoba Therapeutics is a Private company.
-
What is the current valuation of Hoba Therapeutics?
The current valuation of Hoba Therapeutics is .
-
What is Hoba Therapeutics’s current revenue?
The current revenue for Hoba Therapeutics is .
-
How much funding has Hoba Therapeutics raised over time?
Hoba Therapeutics has raised $31M.
-
Who are Hoba Therapeutics’s investors?
Indaco Venture Partners, Medical Incubator Japan, Eir Ventures, European Innovation Council, and Denmark's Export and Investment Fund are 5 of 7 investors who have invested in Hoba Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process